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Abstract
The development of hemoglobin-based oxygen carriers
has been propagated for replacement of the oxygen
carrying properties of red blood cells for almost one cen-
tury. Using a Clark-type multi-wire oxygen surface elec-
trode and the dorsal skin fold chamber model of the
awake Syrian golden hamster, local tissue pO2 was ana-
lyzed in the thin striated skin muscle before and after
administration of an ultrapurified polymerized bovine
hemoglobin solution (U-PBHb®, Biopure Corp., Boston,
Mass., USA) under the following experimental condi-
tions: (a) hypervolemic infusion with U-PBHb at F10% of
calculated blood volume, and (b) isovolemic exchange
transfusion with U-PBHb by replacing F50% of calcu-
lated blood volume. Control animals of group a received
equivalent treatment with either isotonic saline or dex-
tran 60, control animals of group b received dextran 60.
Local tissue pO2 was found slightly decreased after both
hypervolemic infusion and isovolemic exchange transfu-
sion with U-PBHb, while frequency distribution curves of
local tissue pO2 were found more narrow (less values
!10 mm Hg and 125 mm Hg), suggesting a more homo-
geneous tissue pO2 distribution. The data thus indicate
that U-PBHb slightly decreases mean tissue pO2 after
both hypervolemic infusion and isovolemic exchange
transfusion which is accompanied by an effective ho-
mogenization of local tissue pO2 distribution as com-
pared to dextran 60.
Copyright © 2002 S. Karger AG, Basel
Introduction
Red cell substitutes derived from either recombinant,
transgenic, or chemically modified natural hemoglobins
are a promising approach to cover the enormous demand
for red blood cell concentrates. Some of those have mean-
while also undergone clinical phase I and II trials in
healthy volunteers and patients, respectively [1, 2].
U-PBHb® is an iso-oncotic solution of glutaraldehyde-
polymerized ·- and ß-chains of bovine hemoglobin. This
material has previously been investigated in a microcircu-
lation model in the hamster allowing chronic visualiza-
tion of the intact microcirculation of striated skin muscle
in conscious animals: even under the condition of resusci-
tation from hemorrhagic shock, no enhancement of leuko-
cyte/endothelial cell interaction or macromolecular leak-
age across the microvascular wall was observed indicating
the abscence of unwanted side effects in the microcircula-
tion during ischemia/reperfusion. U-PBHb was found a
safe resuscitation fluid, superior to commonly used resus-
citation fluids like Ringer’s solution or dextran 60 [3].
Hemoglobin
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Table 1. Properties of U-PBHb solutions
Parameter U-PBHb®
13 g/dl
Methemoglobin content !10%
pO50 34 mm Hg
pH 7.8
Colloid osmotic pressure 20 mm Hg
Osmolarity 295 mmol/kg
Na+ 150 mmol/l
K+ 4.0 mmol/l
Cl– 145 mmol/l
Mr 64–500 kDa
Phospholipids !3 nmol/ml
Endotoxin content !0.5 EU/ml
Data provided by Biopure Corp., Boston,
Mass., USA.
The aim of the present study was to prove these micro-
circulatory effects of U-PBHb as an oxygen-carrying red
cell substitute by assessing both mean tissue pO2 and its
spatial distribution pattern. This is of particular interest
due to the influence of the hemoglobin molecule on arteri-
olar constriction and its sequelae on local tissue oxygena-
tion. To allow direct comparability to our microcircula-
tion study in the striated skin muscle [3], we used the
same animal model and experimental protocols for analy-
sis of local tissue pO2. Animals were subjected to the pro-
tocols of (a) hypervolemic infusion and (b) isovolemic
exchange transfusion of F50% of the estimated blood
volume to a hematocrit of F30%, thus providing direct
correlation between the already obtained microcircula-
tion data and tissue oxygenation properties. Mean tissue
pO2 and spatial pO2 distribution were monitored prior to
and after administration of U-PBHb or respective control
fluids using the Clark-type multi-wire oxygen surface elec-
trode [4, 5].
Material and Method
Animal Model
Effects of hypervolemic infusion and isovolemic exchange trans-
fusion on local tissue pO2 were analyzed in male Syrian golden ham-
sters (6–8 weeks old, 50–70 g body weight). All experiments were
performed in accordance with the Guide for the Care and Use of
Laboratory Animals (NIH Publication No. 80-23, revised 1985). Fit-
ted with a dorsal skin fold chamber [6, 7], the preparation allows
either intravital microscopic investigation or local tissue pO2 analy-
sis of a thin striated skin muscle consisting of arterioles, capillaries,
and postcapillary venules contained within the observation window.
Chamber implantation and catheterization of the left carotid artery
and jugular vein were performed under intraperitoneal pentobarbital
anesthesia (60 mg/kg body weight, Nembutal®, Abbott, Wiesbaden,
Germany) as previously described [3, 8]. Measurements were made
after a recovery period of at least 24–48 h to eliminate the effects of
surgical intervention and anesthesia. Only animals showing no alter-
ations in sleeping, feeding, and hygiene habits, and no signs of
inflammation, edema, or low flow perfusion in the microvascular bed
[9] underwent the experimental protocols.
Local Tissue pO2 Measurements
Using the Clark-type oxygen multi-wire surface electrode (MDO,
Trolag, Schwabach, Germany) as introduced by Kessler and Lübbers
[4, 5], both mean tissue pO2 and its local distribution can be ana-
lyzed. The electrode consists of eight platinum wires and allows
simultaneous monitoring of eight different tissue points by recording
the pO2 signals from a spheroid tissue volume of 12 mm in diameter.
The employment of a micromanipulator [10] facilitates the gentle
movement of the electrode in 8–10 0.5-mm steps permitting assess-
ment of pO2 at n = 64–80 local data points per animal and time point
of investigation. The pO2 values were registered from the striated
skin muscle and classified into 5-mm ranges versus frequency of
occurrence. Therefore, the method allows measurement of both spa-
tial and temporal variations of local tissue pO2 values which range
between zero and the arterial pO2 [5]. With use of this method, the
pO2 distribution curve from the hamster dorsal skin fold tissue has
been shown to be highly reproducible [11, 12] at baseline values in
the range of 19.5 B 1 mm Hg. These values are distinct from those
reported for skeletal muscle tissue [4, 5, 13–15]. To permit superfu-
sion of the tissue with isotonic saline (Delta Pharma GmbH, Pful-
lingen, Germany) and placement of the electrode, the cover slip of
the skin fold chamber had to be removed from the observation win-
dow of titanium chambers before performance of the measurements.
This procedure has been shown not to alter the microvascular perfu-
sion and leukocyte/endothelial cell interaction in the underlying tis-
sue when gently performed [16]. As reported by other researchers
[17], the tissue temperature was kept between 24 and 26°C, while
calibration and experimental measurements were performed.
Hemoglobin Solutions
The ultrapurified polymerized bovine hemoglobin solution (U-
PBHB®, table 1) was obtained from Biopure Corp. (Boston, Mass.,
USA). Preparation was performed in accordance with previously
described techniques [18–20] consisting of hypertonic lysis of the
blood cells, filtration, chromatography, and polymerization with glu-
taraldehyde and storage at room temperature. In comparison to
human hemoglobin, the amino acid composition of an ·ß-dimer of
bovine hemoglobin shows 28 substitutions, whereof two are located
in the ß-chain and are suggested relevant for the decreased oxygen
affinity of bovine hemoglobin when compared to human [21]. Fur-
thermore, the oxygen affinity is not regulated by 2,3-diphosphogly-
cerate (2,3-DPG) but by chloride ions [22]. Therefore, in a cell-free
preparation of bovine hemoglobin, there is no increase in oxygen
affinity due to absence of intracellular allosteric regulators. The same
solution has already been reported in a microcirculation study on
safety and toxicity [3].
Experimental Design
The macrohemodynamic parameters mean arterial pressure
(MAP) and heart rate (HR) were continuously monitored during the
Hypervolemic infusion
Hypervolemic infusion
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Table 2. Mean arterial pressure (MAP)
before and after hypervolemic infusion and
isovolemic exchange transfusion
MAP, mm Hg
baseline 5 min 25 min 40 min 55 min 70 min
NaCl 0.9 % 100B7 105B7 100B7 95B8 100B6 105B6
Dextran 60 100B7 100B6 95B8 105B6 102B5 100B7
U-PBHb 100B7 115B6 113B7 117B4 109B10 111B8
Isovolemic exchange transfusion
Dextran 60 100B7 102B6 98B4 105B4 102B6 98B4
U-PBHb 100B7 120B6 115B6 118B4 110B5 115B4
Table 3. Heart rate (HR) before and after
hypervolemic infusion and isovolemic
exchange transfusion
HR, min–1
baseline 5 min 25 min 40 min 55 min 70 min
NaCl 0.9 % 352B25 335B23 352B25 371B30 351B23 335B21
Dextran 60 352B25 351B23 371B30 335B21 345B16 352B25
U-PBHb 352B25 305B17 310B20 300B10 323B29 318B26
Isovolemic exchange transfusion
Dextran 60 352B25 345B19 356B13 334B13 345B19 356B13
U-PBHb 352B25 292B14 305B15 298B9 319B14 305B11
experiments using a Statham element (PD 23, Gould Statham, Calif.,
USA) connected to the indwelling carotid catheter and to a micro-
pressure transducer and cardiovascular analyzer (Type Brush 2400,
Gould-Allco, Ballainvilliers, France). In consistence with a previous
microcirculatory study [3], the experimental protocol was as follows.
Hypervolemic Infusion
The influence of a low-dose administration of U-PBHb on the
microcirculation of the striated skin muscle was determined by infus-
ing the animals with 5 ml per kg body weight (F10% total blood
volume; 500 mg/kg) of either isotonic saline (Delta Pharma GmbH,
Pfullingen, Germany), 6% dextran 60 (Dx-60, Schiwa GmbH, Glan-
dorf, Germany) or bovine hemoglobin solution (U-PBHb). Measure-
ments of pO2 values were performed prior to hypervolemic infusion
(baseline) and 10, 30, and 60 min thereafter.
Isovolemic Exchange Transfusion
The effect of a 5.5-fold higher dose of U-PBHb was assessed by
exchange transfusion of the animals with either 6% dextran 60 or
hemoglobin solution at a rate of 0.3 ml/min i.v. to a final hematocrit
of 30 B 3%. The exchange volume amounted to F50% of total blood
volume which was calculated from 7% of total body weight [23].
Measurements of pO2 values were made prior to exchange transfu-
sion (baseline) and 10, 30, and 60 min thereafter.
Experimental Design
Thirty animals fulfilling the entry criteria [6] were involved in the
study: 18 of them underwent hypervolemic infusion grouped into
isotonic saline-treated animals (n = 6), dextran 60-treated animals
(n = 6), and those who received U-PBHb (n = 6). Another 12 animals
were subjected to the isovolemic exchange transfusion protocol and
grouped into dextran 60 (n = 6) and U-PBHb-treated animals
(n = 6).
Statistics
All data are given as mean B standard deviation (SD). For all
statistical tests the minimum level of significance considered was 5%
(p ! 0.05). For differences between groups, time-related changes were
assessed with Kruskal-Wallis ANOVA (Sigma Stat® Version 1.0,
1992–1994, Jandel Corp., USA), for differences within groups (re-
peated measurements), Student-Newman-Keuls test was applied.
Results
Hypervolemic Infusion
MAP and HR. Under baseline conditions, MAP and
HR ranged between 95 and 105 mm Hg and between 300
and 400 beats per minute, respectively. Hypervolemic
infusion of isotonic saline or dextran 60 caused no
changes of these parameters, whereas application of U-
PBHb initiated an immediate increase in MAP by F15%
which remained elevated during the entire observation
time of 60 min and a HR response in reciprocal manner
(table 2, 3).
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Fig. 1. Spatial distribution of tissue pO2
before and after hypervolemic infusion of
isotonic saline (n = 6, mean B SD).
Fig. 2. Spatial distribution of tissue pO2
before and after hypervolemic infusion of
dextran 60 (n = 6, mean B SD).
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Fig. 3. Spatial distribution of tissue pO2
before and after hypervolemic infusion of
U-PBHb (n = 6, mean B SD).
Local Tissue pO2. Mean local tissue pO2 in striated
skin muscle after hypervolemic infusion of normal saline
and dextran 60 disclosed no changes when compared with
preinfusion values, while a 17% decrease was observed
1 h after infusion of U-PBHb (fig. 6). Analysis of the
underlying local tissue pO2 distribution curves demon-
strates that mean local tissue pO2 under baseline condi-
tions and after treatment with either normal saline or dex-
tran 60 mainly results from values in the ranges of 15–20
and 20–25 mm Hg (fig. 1–3), while application of U-
PBHb led to a left shift of this distribution pattern by
5 mm Hg (fig. 3).
Isovolemic Exchange Transfusion
MAP and HR. Exchange transfusion with U-PBHb
resulted in a 20% increase of MAP which was seen during
the entire observation period and – similar to the results
of hypervolemic infusion – in a HR response in reciprocal
manner. These changes were absent after exchange trans-
fusion with dextran 60, where only a slight decrease in
MAP was noted (table 2, 3).
Local Tissue pO2. Mean local tissue pO2 in striated
skin muscle decreased by 7% 1 h after isovolemic ex-
change transfusion with dextran 60, and by 27% after use
of U-PBHb, respectively (fig. 7). While isovolemic ex-
change transfusion with dextran 60 did not alter tissue
pO2 distribution pattern (fig. 4), the treatment with U-
PBHb resulted in a left shift by 5 mm Hg and a narrowing
of this pattern (fig. 5), meeting the demand of adequate
tissue oxygenation and avoiding tissue hypoxia (values in
the range of 0–5 mm Hg).
Discussion
The present study suggests the effective homogeniza-
tion of local tissue pO2 by U-PBHb by providing a more
homogeneous distribution of local tissue oxygen tensions
under the condition of isovolemic exchange tranfusion as
assessed in the striated skin muscle of conscious Syrian
golden hamsters.
Similar to findings by others with U-PBHb [24, 25],
further compositions of bovine [26, 27] and other mam-
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Fig. 4. Spatial distribution of tissue pO2
before and after isovolemic exchange trans-
fusion of dextran 60 (n = 6, mean B SD).
Fig. 5. Spatial distribution of tissue pO2
before and after isovolemic exchange trans-
fusion of U-PBHb (n = 6, mean B SD).
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Fig. 6. Mean tissue pO2 before and after hypervolemic infusion (n =
6, mean B SD). * p ! 0.05 vs. baseline (Student-Newman-Keuls-
test), † p ! 0.05 vs. 6% dextran 60 (Kruskal-Wallis-test).
Fig. 7. Mean tissue pO2 before and after isovolemic exchange trans-
fusion (n = 6, mean B SD). * p ! 0.05 vs. baseline (Student-Newman-
Keuls-test), † p ! 0.05 vs. 6% dextran 60 (Kruskal-Wallis-test).
malian hemoglobins [8, 28] and similar to our own find-
ings with U-PBHb [3], a significant elevation of mean
arterial pressure has been found accompanied by reflex
bradycardia following infusion of these solutions. The
effect may be explained by the scavenge of NOW by hemo-
globin via formation of S-nitrosohemoglobin within the
vascular bed [26, 29–31]. This mechanism is of particular
interest in this context, since vasoconstriction – and as a
consequence flowmotion – is known to influence local tis-
sue pO2 [32–34].
We assume hemoglobin to cause a modulation of vaso-
motion, since the application of U-PBHb is accompanied
by a homogenization of the distribution pattern of local
tissue pO2, assessed with the Clark-type multi-wire sur-
face electrode. After isovolemic exchange transfusion, the
effect was even more pronounced than after hypervolemic
infusion and the procedure simultaneously resulted in a
decrease of mean local tissue pO2. At the end of the obser-
vation period, no increase of hypoxic values (0–5 mm Hg)
was registered suggesting that this phenomenon may be
interpreted not to be harmful to the tissue. Other re-
searchers even found tissue oxygenation improved after
isovolemic hemodilution to a hematocrit of F10% using
U-PBHb as compared to autologous stored red cells [35].
Due to the demonstration of a more homogeneous pO2
distribution pattern, we claim U-PBHb to economize oxy-
gen distibution by lessening areas of inadequately high or
low tissue oxygen tension. This is consistent with findings
of raised tissue oxygenation yielding improved organ
function and morphology, when U-PBHb was compared
to an iso-oncotic perfusion fluid in rat kidneys [36].
In summary, this study provides in vivo evidence that
U-PBHb significantly improves the homogeneity of local
tissue oxygenation. To clarify whether these effects hold
true under the conditions of severe ischemia and reperfu-
sion, further trials with U-PBHb, especially under the
conditions of severe hemorrhagic shock, have to be under-
taken.
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